Improved outcomes from a comprehensive management system for heart failure

2001 ◽  
Vol 3 (5) ◽  
pp. 619-625 ◽  
Author(s):  
Diane P. Holst ◽  
David Kaye ◽  
Meroula Richardson ◽  
Henry Krum ◽  
David Prior ◽  
...  
1999 ◽  
Vol 5 (3) ◽  
pp. 44 ◽  
Author(s):  
Di Holst ◽  
David Kaye ◽  
Meroula Richardson ◽  
Henry Krum ◽  
David Prior ◽  
...  

2000 ◽  
Vol 9 (3) ◽  
pp. A84
Author(s):  
D. Holst ◽  
D. Kaye ◽  
M. Richardson ◽  
H. Krum ◽  
D. Prior ◽  
...  

1997 ◽  
Vol 79 (1) ◽  
pp. 58-63 ◽  
Author(s):  
Jeffrey A West ◽  
Nancy H Miller ◽  
Kathleen M Parker ◽  
Deborah Senneca ◽  
Ghassan Ghandour ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Emmanuel Aja Oga ◽  
Olabimpe Ruth Eseyin

There is scientific consensus that obesity increases the risk of cardiovascular diseases, including heart failure. However, among persons who already have heart failure, outcomes seem to be better in obese persons as compared with lean persons: this has been termed theobesity paradox, the mechanisms of which remain unclear. This study systematically reviewed the evidence of the relationship between heart failure mortality (and survival) and weight status. Search of the PubMed/MEDLINE and EMBASE databases was done according to the PRISMA protocol. The initial search identified 9879 potentially relevant papers, out of which ten studies met the inclusion criteria. One study was a randomized clinical trial and 9 were observational cohort studies: 6 prospective and 3 retrospective studies. All studies used the BMI, WC, or TSF as measure of body fatness and NYHA Classification of Heart Failure and had single outcomes, death, as study endpoint. All studies included in review were longitudinal studies. All ten studies reported improved outcomes for obese heart failure patients as compared with their normal weight counterparts; worse prognosis was demonstrated for extreme obesity (BMI>40 kg/m2). The findings of this review will be of significance in informing the practice of asking obese persons with heart failure to lose weight. However, any such recommendation on weight loss must be consequent upon more conclusive evidence on the mechanisms of the obesity paradox in heart failure and exclusion of collider bias.


Author(s):  
Sidhi Laksono Purwowiyoto ◽  
Ananta Siddhi Prawara

Heart failure (HF) and metabolic syndrome (MetS) are syndromes that affect a large proportion of the world population. MetS is known to be one of the risk factors of HF, and it can also act as comorbidity in HF. This review aims to further discuss the mechanism of MetS in causing HF, the management of MetS in order to prevent HF, and the management of MetS in HF patients. Visceral adiposity is the primary trigger of MetS which is followed by chronic inflammation, insulin resistance, and neurohormonal activation. All the mechanisms causing MetS play also an important role in the progression of HF. The MetS approach can be achieved by managing its components according to the current guidelines and careful management of MetS should be done in patients with HF. MetS is closely related to the progression of HF so that comprehensive management which involves a multidisciplinary team is necessary for managing patients with metabolic syndrome and heart failure.


Sign in / Sign up

Export Citation Format

Share Document